The RelA/p65 subunit of NF-κB specifically regulates cyclin D1 protein stability: Implications for cell cycle withdrawal and skeletal myogenesis

Journal of Cellular Biochemistry

Volumn 106, Issue 1, 2009, Pages 42-51

  Dahlman, Jason M ^a   Wang, Jingxin ^a   Bakkar, Nadine ^a   Guttridge, Denis C ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle; Myogenesis; Nf kappa b; Cyclin D1; P65; Protein stability; RelA

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLOHEXYLAMINE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN STABILITY; PROTEIN SYNTHESIS;

EID: 58649093547     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21976     Document Type: Article

References (60)

1. Alao JP. 2007. The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Mol Cancer 6:24.
2. Baeuerle PA, Baltimore D. 1996. NF-kappa B: Ten years after. Cell 87:13-20.
3. Baeuerle PA, Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179.
4. Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, Carathers M, Acharyya S, Rudnicki MA, Hollenbach AD, Guttridge DC. 2008. IKK/NF-kappaB
5. regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 180:787-802.
6. Baldwin AS, Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649-683.
7. Baldwin AS, Jr., Azizkhan JC, Jensen DE, Beg AA, Coodly LR. 1991. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol 11:4943-4951.
8. Barbash O, Lin DI, Diehl JA. 2007. SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: A license to destroy. Cell Div 2:2.
9. Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H, Lu F, Rustgi AK, Diehl JA. 2008. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14:68-78.
10. Bash J, Zong WX, Gelinas C. 1997. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol Cell Biol 17:6526-6536.
11. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167-170.
12. BeijersbergenRL, Bernards R. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1287:103-120.
13. Benzeno S, Diehl JA. 2004. C-terminal sequences direct cyclin D1-CRM1 binding. J Biol Chem 279:56061-56066.
14. Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, Kittrell F, Medina D, Matrisian LM, Kerr LD, Yull FE. 2001. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell 12:1445-1455.
15. Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, Karin M. 2001. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammarygland development. Cell 107:763-775.
16. Chen FE, Ghosh G. 1999. Regulation of DNA binding by Rel/NF-kappaB transcription factors: Structural views. Oncogene 18:6845-6852.
17. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583.
18. Cheshire JL, Baldwin AS, Jr. 1997. Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Mol Cell Biol 17:6746-6754.
19. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS, Jr. 2000. Selective activation of NF-kappa B subunits in human breast cancer: Potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19:1123-1131.
20. Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landes-man-Bollag E, Seldin DC, Sonenshein GE. 2005. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol 25:10136-10147.
21. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. 1997.
22. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548-554.
23. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511.
24. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y. 1999. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96:2994-2999.
25. Duyao MP, Buckler AJ, Sonenshein GE. 1990. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci USA 87:4727-4731.
26. Feng B, Cheng S, Hsia CY, King LB, Monroe JG, Liou HC. 2004. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol 232:9-20.
27. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS, Jr. 1999. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19:5785-5799.
28. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS, Jr. 2000. NF-kappaB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 289:2363-2366.
29. Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev 18:2195-2224.
30. Hertlein E, Wang J, Ladner KJ, Bakkar N, Guttridge DC. 2005. RelA/p65 regulation of IkappaBbeta. Mol Cell Biol 25:4956-4968. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. 1999.
31. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19:2690-2698.
32. Karin M. 2006. NF-kappaB and cancer: Mechanisms and targets. Mol Carcinog 45:355-361.
33. Kessler DJ, Spicer DB, La Rosa FA, Sonenshein GE. 1992. A novel NF-kappa B element within exon 1 of the murine c-myc gene. Oncogene 7:2447-2453.
34. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-491.
35. Li Z, Nabel GJ. 1997. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription. Mol Cell Biol 17:6184-6190.
36. Li Q, Verma IM. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734.
37. Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA. 2006. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystalline) complex. Mol Cell 24:355-366.
38. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493-504.
39. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S. 1996. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 78:390-395.
40. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076.
41. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866.
42. Monden N, Nishizaki K, Fukushima K, Masuda Y, Tsukuda K, Shimizu K. 1997. Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas. Jpn J Cancer Res 88:660-668.
43. MullerM, Morotti A, Ponzetto C. 2002. Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol 22:1060-1072.
44. Naderi S, Blomhoff HK. 1999. Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: Regulation of cyclin E, cyclin A, and p21(Cip1). Blood 94:1348-1358.
45. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17:5338-5347.
46. Park SG, Chung C, Kang H, Kim JY, Jung G. 2006. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. J Biol Chem 281:31770-31777.
47. Rando TA, Blau HM. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125: 1275-1287.
48. Rao SS, Kohtz DS. 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J Biol Chem 270:4093-4100.
49. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. 1997. Identification and characterization of an IkappaB kinase. Cell 90:373-383.
50. Rocha S, Martin AM, Meek DW, Perkins ND. 2003. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 23:4713-4727.
51. Sherr CJ. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
52. Simpson JF, Quan DE, O'Malley F, Odom-Maryon T, Clarke PE. 1997.
53. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151:161-168.
54. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. 1995. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev 9:2723-2735.
55. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
56. Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin AS, Jr. 2001. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. Mol Cell Biol 21:8428-8436.
57. Whiteside ST, Epinat JC, Rice NR, Israel A. 1997. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16:1413-1426.
58. Worsley SD, Jennings BA, Khalil KH, Mole M, Girling AC. 1996. Cyclin D1 amplification and expression in human breast carcinoma: Correlation with histological prognostic markers and oestrogen receptor expression. Clin Mol Pathol 49:M46-M50.
59. Zandi E, Rothwarf DM, DelhaseM, Hayakawa M, KarinM. 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252.
60. Zhou A, Scoggin S, Gaynor RB, Williams NS. 2003. Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference. Oncogene 22:2054-2064.